Amgen experimental lung cancer drug shows promise in study

More than half of patients with an advanced form of lung cancer initially responded to an experimental Amgen drug that targets a genetic driver of the disease.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news